246 related articles for article (PubMed ID: 8768797)
1. S-protein/vitronectin interaction with the C5b and the C8 of the complement membrane attack complex.
Su HR
Int Arch Allergy Immunol; 1996 Aug; 110(4):314-7. PubMed ID: 8768797
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
Brannen CL; Sodetz JM
Mol Immunol; 2007 Feb; 44(5):960-5. PubMed ID: 16624411
[TBL] [Abstract][Full Text] [Related]
3. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
Milis L; Morris CA; Sheehan MC; Charlesworth JA; Pussell BA
Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159
[TBL] [Abstract][Full Text] [Related]
4. Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.
Stewart JL; Kolb WP; Sodetz JM
J Immunol; 1987 Sep; 139(6):1960-4. PubMed ID: 3624872
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
6. The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8, and C9 and perforin from cytolytic T-cells and inhibits their lytic activities.
Tschopp J; Masson D; Schäfer S; Peitsch M; Preissner KT
Biochemistry; 1988 May; 27(11):4103-9. PubMed ID: 2458130
[TBL] [Abstract][Full Text] [Related]
7. Increased ion permeability of planar lipid bilayer membranes after treatment with the C5b-9 cytolytic attack mechanism of complement.
Michaels DW; Abramovitz AS; Hammer CH; Mayer MM
Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2852-6. PubMed ID: 1066698
[TBL] [Abstract][Full Text] [Related]
8. Single-molecule kinetics of pore assembly by the membrane attack complex.
Parsons ES; Stanley GJ; Pyne ALB; Hodel AW; Nievergelt AP; Menny A; Yon AR; Rowley A; Richter RP; Fantner GE; Bubeck D; Hoogenboom BW
Nat Commun; 2019 May; 10(1):2066. PubMed ID: 31061395
[TBL] [Abstract][Full Text] [Related]
9. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
Podack ER; Tschoop J; Müller-Eberhard HJ
J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
[TBL] [Abstract][Full Text] [Related]
10. Recombinant C345C and factor I modules of complement components C5 and C7 inhibit C7 incorporation into the complement membrane attack complex.
Thai CT; Ogata RT
J Immunol; 2005 May; 174(10):6227-32. PubMed ID: 15879120
[TBL] [Abstract][Full Text] [Related]
11. Membrane attack complex of complement: generation of high-affinity phospholipid binding sites by fusion of five hydrophilic plasma proteins.
Podack ER; Biesecker G; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):897-901. PubMed ID: 284414
[TBL] [Abstract][Full Text] [Related]
12. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
Lehto T; Meri S
J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
[TBL] [Abstract][Full Text] [Related]
13. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.
Joiner KA; Hammer CH; Brown EJ; Frank MM
J Exp Med; 1982 Mar; 155(3):809-19. PubMed ID: 6801180
[TBL] [Abstract][Full Text] [Related]
14. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
Tschopp J; Chonn A; Hertig S; French LE
J Immunol; 1993 Aug; 151(4):2159-65. PubMed ID: 8345200
[TBL] [Abstract][Full Text] [Related]
15. Membrane attack by complement.
Podack ER; Tschopp J
Mol Immunol; 1984 Jul; 21(7):589-603. PubMed ID: 6379417
[TBL] [Abstract][Full Text] [Related]
16. Evidence of direct insertion of terminal complement proteins into cell membrane bilayers during cytolysis. Labeling by a photosensitive membrane probe reveals a major role for the eighth and ninth components.
Steckel EW; Welbaum BE; Sodetz JM
J Biol Chem; 1983 Apr; 258(7):4318-24. PubMed ID: 6833260
[TBL] [Abstract][Full Text] [Related]
17. Supported Lipid Bilayer Platform To Test Inhibitors of the Membrane Attack Complex: Insights into Biomacromolecular Assembly and Regulation.
Yorulmaz S; Jackman JA; Hunziker W; Cho NJ
Biomacromolecules; 2015 Nov; 16(11):3594-602. PubMed ID: 26444518
[TBL] [Abstract][Full Text] [Related]
18. Formation of the terminal complement complex on agarose beads: further evidence that vitronectin (complement S-protein) inhibits C9 polymerization.
Johnson E; Berge V; Høgåsen K
Scand J Immunol; 1994 Mar; 39(3):281-5. PubMed ID: 7510414
[TBL] [Abstract][Full Text] [Related]
19. The membrane attack mechanism of complement: photolabeling reveals insertion of terminal proteins into target membrane.
Hu VW; Esser AF; Podack ER; Wisnieski BJ
J Immunol; 1981 Jul; 127(1):380-6. PubMed ID: 7240749
[TBL] [Abstract][Full Text] [Related]
20. Effect of agents that produce membrane disorder on lysis of erythrocytes by complement.
Shin ML; Hänsch G; Mayer MM
Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2522-5. PubMed ID: 6941304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
